CellVoyant logo

CellVoyant jobs and careers

Bristol, United Kingdom

About CellVoyant

CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have the best investors behind us from day 1. We’re backed by venture capital firms who were the earliest investors in AI pioneer DeepMind, the two leading AI-first drug discovery companies, Exscientia and Recursion, and self-driving challenger Wayve. We’re also supported by the founder/CEO of Abcam, which pioneered the antibody business.

Founded in 2021 by Rafael E. Carazo.

Founded
2021
Employees
1 to 10
Total funding
$7.6M
Headquarters
Bristol

Leadership

The top of CellVoyant's org chart, with how many people report into each leader.

RS

Rafael E. Carazo Salas

Founder/CEO

11 reports

SMPhoto of Saad M.

Saad M.

Ml/ai Science Lead

8 reports

EWPhoto of Eugenia Wachters

Eugenia Wachters

Chief Operating Officer

EWPhoto of Elaine Williams

Elaine Williams

Operations Manager